Results 11 to 20 of about 40,592 (266)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue

open access: yesJournal of Asthma and Allergy, 2023
Njira Lugogo,1 Ileen Gilbert,2 Michael Pollack,2 Hitesh Gandhi,2 Joseph Tkacz,3 Miguel J Lanz4 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA; 2BioPharmaceuticals Medical, AstraZeneca,
Lugogo N   +5 more
doaj  

Once-daily use of inhaled corticosteroids: A new regimen in the treatment of persistent asthma

open access: yesAllergology International, 2000
Asthma is a disease of chronic airway inflammation that is characterized clinically by bronchial hyper-responsiveness and airflow limitation. Chronic inflammation, coupled with ongoing repair of airways damaged by the persistent inflammatory process in ...
Jeffrey Leflein
doaj   +1 more source

RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView., 2023
Retraction: Tan, DJY, Ko, TK. Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis. World J Otorhinolaryngol Head Neck Surg. 2023; 1–8. doi:10.1002/wjo2.125. The above article, published online on 28 July 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor ...
Denise Jia Yun Tan, Tsz Ki Ko
wiley   +1 more source

High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma

open access: yesTherapeutic Advances in Respiratory Disease, 2016
The high-strength formulation of extrafine beclometasone dipropionate/formoterol fumarate (BDP/Form) 200/6 µg has been developed to step up inhaled corticosteroid treatment, without increasing the dose of the bronchodilator, in patients who are not ...
Massimo Corradi   +3 more
doaj   +1 more source

Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebo-controlled, double-blind clinical trial

open access: yesSão Paulo Medical Journal, 2001
CONTEXT: Budesonide is an inhaled corticosteroid with high topical potency and low systemic activity recommended in the treatment of chronic asthma. OBJECTIVE: This study was conducted to determine the efficacy and safety of inhaled budesonide via a ...
Ana Luisa Godoy Fernandes   +5 more
doaj   +1 more source

Risk factors of laryngeal cryptococcosis: A case report

open access: yesMedical Mycology Case Reports, 2019
Cryptococcal infections are acquired by inhalation of encapsulated yeast cells or basidiospores. While Cryptococcus has a propensity to invade the lungs and central nervous system, other sites can be affected.
Orlando Quintero   +5 more
doaj   +1 more source

Inhaled corticosteroids for cystic fibrosis [PDF]

open access: yes, 2000
Maintenance of optimal lung function is an important therapeutic goal in cystic fibrosis as it is lung damage that, in the long term, is responsible for most premature death among affected people. Inhaled corticosteroids are being increasingly used to treat children and adults with cystic fibrosis.
C, Dezateux, S, Walters, I, Balfour-Lynn
openaire   +2 more sources

Inhaled Corticosteroids in Lung Diseases [PDF]

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2013
Abstract Inhaled corticosteroids (ICSs) are used extensively in the treatment of asthma and chronic obstructive pulmonary disease (COPD) due to their broad antiinflammatory effects. They improve lung function, symptoms, and quality of life and reduce exacerbations in both conditions but do not alter the progression of disease.
Hengameh H, Raissy   +3 more
openaire   +2 more sources

Differences in the Prescription Patterns of Anti-asthmatic Medications for Children by Pediatricians, Family Physicians and Physicians of Other Specialties

open access: yesJournal of the Formosan Medical Association, 2006
Prescription patterns of anti-asthma medications in children vary among doctors in different disciplines and settings, and may reflect differences in treatment outcome.
Hai-Lun Sun   +4 more
doaj   +1 more source

Impact of the corticosteroid indication and administration route on overall survival and the tumor response after immune checkpoint inhibitor initiation

open access: yesTherapeutic Advances in Medical Oncology, 2021
Background: Based on their indications, systemic corticosteroids appear to negatively affect clinical outcomes in immune checkpoint inhibitor (ICI)-treated patients.
Louis Gaucher   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy